These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16444629)
1. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis. Kuryata OV; Yegorova YV Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629 [TBL] [Abstract][Full Text] [Related]
2. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk. Velussi M Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227 [TBL] [Abstract][Full Text] [Related]
3. Advances in drug treatment of dyslipidemia: focus on atorvastatin. Davignon J Can J Cardiol; 1998 May; 14 Suppl B():28B-38B. PubMed ID: 9627539 [TBL] [Abstract][Full Text] [Related]
4. Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia. Nordøy A; Hansen JB; Brox J; Svensson B Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):7-16. PubMed ID: 11383326 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of atorvastatin in treating high risk patients to reach low density lipoprotein-cholesterol goals: the Treat to Target (TTT-Israel) Study. Leibovitz E; Harats D; Gavish D Isr Med Assoc J; 2002 Jun; 4(6):407-10. PubMed ID: 12073409 [TBL] [Abstract][Full Text] [Related]
6. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia. Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426 [TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation. Demetriou D; Shabpar A; Böhmig G; Schmaldienst S; Hörl WH; Watschinger B Wien Klin Wochenschr; 2000 Apr; 112(8):358-61. PubMed ID: 10849941 [TBL] [Abstract][Full Text] [Related]
8. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630 [TBL] [Abstract][Full Text] [Related]
9. An assessment of the efficacy of atorvastatin in treating patients with dyslipidaemia to target LDL-cholesterol goals: the atorvastatin matrix study. McVey D; Patel H; Eminton Z; Maton S Int J Clin Pract; 1999; 53(7):509-13. PubMed ID: 10692735 [TBL] [Abstract][Full Text] [Related]
10. Atorvastatin plus pravastatin for the treatment of heterozygous familial hypercholesterolaemia--a pilot study. Athyros VG; Papageorgiou AA; Demitriadis DS; Kontopoulos AG Curr Med Res Opin; 2001; 17(4):267-72. PubMed ID: 11922400 [TBL] [Abstract][Full Text] [Related]
11. Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: a randomized, placebo-controlled study. Schrott HG; Knapp H; Davila M; Shurzinske L; Black D Am Heart J; 2000 Aug; 140(2):249-52. PubMed ID: 10925339 [TBL] [Abstract][Full Text] [Related]
12. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects. Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702 [TBL] [Abstract][Full Text] [Related]
13. Short-term effects of atorvastatin on C-reactive protein. Riesen WF; Engler H; Risch M; Korte W; Noseda G Eur Heart J; 2002 May; 23(10):794-9. PubMed ID: 12009719 [TBL] [Abstract][Full Text] [Related]
14. Atorvastatin increases HDL cholesterol in hypercholesterolemic patients. Evidence of a relationship with baseline HDL cholesterol. Branchi A; Fiorenza AM; Torri A; Muzio F; Berra C; Colombo E; Dalla Valle E; Rovellini A; Sommariva D Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):24-8. PubMed ID: 12125226 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitor. Stern RH; Yang BB; Hounslow NJ; MacMahon M; Abel RB; Olson SC J Clin Pharmacol; 2000 Jun; 40(6):616-23. PubMed ID: 10868312 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of atorvastatin 10 mg every other day in hypercholesterolemia. Piamsomboon C; Laothavorn P; Saguanwong S; Chatlaong B; Nasawadi C; Tanprasert P; Pongsiri K J Med Assoc Thai; 2002 Mar; 85(3):297-300. PubMed ID: 12117017 [TBL] [Abstract][Full Text] [Related]
17. Use of atorvastatin in hyperlipidemic hypertensive renal transplant recipients. Krmar RT; Ferraris JR; Ramirez JA; Sorroche P; Legal S; Cayssials A Pediatr Nephrol; 2002 Jul; 17(7):540-3. PubMed ID: 12172771 [TBL] [Abstract][Full Text] [Related]
18. Effects of statins on biomarkers of bone metabolism: a randomised trial. Stein EA; Farnier M; Waldstreicher J; Mercuri M; Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):84-7. PubMed ID: 11434192 [TBL] [Abstract][Full Text] [Related]
19. Increased superoxide anion production by platelets in hypercholesterolemic patients. Sanguigni V; Pignatelli P; Caccese D; Pulcinelli FM; Lenti L; Magnaterra R; Martini F; Lauro R; Violi F Thromb Haemost; 2002 May; 87(5):796-801. PubMed ID: 12038779 [TBL] [Abstract][Full Text] [Related]
20. The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT). Youssef F; Seifalian AM; Jagroop IA; Myint F; Baker D; Mikhailidis DP; Hamilton G Eur J Vasc Endovasc Surg; 2002 Apr; 23(4):358-64. PubMed ID: 11991700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]